ASP Isotopes (NASDAQ:ASPI) Coverage Initiated at Canaccord Genuity Group

Canaccord Genuity Group began coverage on shares of ASP Isotopes (NASDAQ:ASPI) in a note issued to investors on Friday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $4.50 price target on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 45.16% from the company’s previous close.

Separately, HC Wainwright decreased their target price on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th.

ASP Isotopes Stock Performance

ASPI opened at $3.10 on Friday. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 2.06. The firm has a market cap of $160.47 million, a PE ratio of -5.85 and a beta of 5.11. The business has a fifty day simple moving average of $2.48 and a 200-day simple moving average of $3.32. ASP Isotopes has a fifty-two week low of $0.84 and a fifty-two week high of $5.67.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The company had revenue of $1.02 million during the quarter. As a group, equities analysts predict that ASP Isotopes will post -0.24 EPS for the current fiscal year.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, major shareholder Ak Jensen Investment Managemen purchased 70,000 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The shares were purchased at an average cost of $3.05 per share, with a total value of $213,500.00. Following the completion of the transaction, the insider now owns 6,586,874 shares of the company’s stock, valued at approximately $20,089,965.70. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 26.30% of the stock is currently owned by insiders.

Institutional Trading of ASP Isotopes

Institutional investors have recently made changes to their positions in the stock. Fielder Capital Group LLC purchased a new stake in ASP Isotopes in the 2nd quarter worth approximately $55,000. Rhumbline Advisers purchased a new stake in shares of ASP Isotopes during the second quarter worth $116,000. HTLF Bank boosted its position in ASP Isotopes by 197.0% during the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after purchasing an additional 70,000 shares during the last quarter. Virtu Financial LLC grew its stake in ASP Isotopes by 477.0% in the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after purchasing an additional 69,176 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in ASP Isotopes in the second quarter valued at about $381,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.